Menu

• Ask a Health Expert about HAEMATOCRIT DECREASED
• Post Your Side Effect related to HAEMATOCRIT DECREASED
• HAEMATOCRIT DECREASED and FDA Warnings
• HAEMATOCRIT DECREASED in Patients Wiki
• Report HAEMATOCRIT DECREASED in Drug Side Effect Survey

HAEMATOCRIT DECREASED side effect

What is HAEMATOCRIT DECREASED ?

A Health Expert wants to answer your question. Please provide details below.

Type your question here

 letters left

Aspirin Side Effects Report #5650718-8
Consumer or non-health professional from UNITED STATES reported ASPIRIN problem on Feb 21, 2008. Female patient, 67 years of age, weighting 119.0 lb, was diagnosed with percutaneous coronary intervention and was treated with ASPIRIN. After drug was administered, patient experienced the following problems/side effects: haematocrit decreased, haemoglobin decreased, . ASPIRIN dosage: TOTAL DAILY DOSE: 162 MG. During the same period patient was treated with CLOPIDOGREL, EPTIFIBATIDE, HEPARIN. Patient was hospitalized. Patient recovered.

Gemzar Side Effects Report #5660808-1
GEMZAR problem was reported by a Physician from JAPAN on Feb 28, 2008. Male patient, weighting 143.5 lb, was diagnosed with large cell lung cancer stage iv, pain and was treated with GEMZAR. After drug was administered, patient experienced the following problems/side effects: haematocrit decreased, haemoglobin decreased, lymphadenopathy, lymphocyte count decreased, malignant neoplasm progression, metastases to peritoneum, pneumocystis jiroveci pneumonia, red blood cell count decreased, renal impairment, . GEMZAR dosage: 1400 MG, OTHER. During the same period patient was treated with CISPLATIN, VOLTAREN, LENDORMIN, GASTER D, LOXONIN, NORVASC. Patient was hospitalized. Patient recovered.

Decadron Side Effects Report #5661101-3
Consumer or non-health professional from UNITED STATES reported DECADRON problem on Feb 22, 2008. Male patient, 67 years of age, weighting 200.0 lb, was diagnosed with brain oedema, glioblastoma multiforme and was treated with DECADRON. After drug was administered, patient experienced the following problems/side effects: haematocrit decreased, haemoglobin decreased, hyperglycaemia, nausea, pleural effusion, pneumonia, thrombocytopenia, vomiting, . DECADRON dosage: 4 MG QID PO, 1 MG DAILY PO. During the same period patient was treated with TEMODAR. Patient was hospitalized. Patient recovered.

Boniva Side Effects Report #5661564-3
BONIVA problem was reported by a Health Professional from UNITED STATES on Mar 04, 2008. Female patient, 84 years of age, was diagnosed with osteoporosis and was treated with BONIVA. After drug was administered, patient experienced the following problems/side effects: haematocrit decreased, peptic ulcer haemorrhage, . BONIVA dosage: unknown. Patient recovered.


Triquilar Side Effects Report #5671890-X
Physician from JAPAN reported TRIQUILAR problem on Feb 29, 2008. Female patient, 46 years of age, was diagnosed with oral contraception and was treated with TRIQUILAR. After drug was administered, patient experienced the following problems/side effects: haematocrit decreased, haemoglobin decreased, red blood cell count decreased, uterine cancer, white blood cell count increased, . TRIQUILAR dosage: unknown. Patient recovered.

Mirena Side Effects Report #5681894-9
MIRENA problem was reported by a Consumer or non-health professional from UNITED STATES on Aug 22, 2007. Female patient, 40 years of age, weighting 163.1 lb, was diagnosed with contraception and was treated with MIRENA. After drug was administered, patient experienced the following problems/side effects: haematocrit decreased, haemoglobin decreased, menometrorrhagia, . MIRENA dosage: unknown. During the same period patient was treated with VITAMINS. Patient recovered.

Mycophenolate Side Effects Report #5684981-4
Physician from ARGENTINA reported MYCOPHENOLATE MOFETIL problem on Mar 18, 2008. Female patient, 16 years of age, weighting 127.9 lb, was diagnosed with lupus nephritis and was treated with MYCOPHENOLATE MOFETIL. After drug was administered, patient experienced the following problems/side effects: haematocrit decreased, haemoglobin decreased, infection, lupus nephritis, renal failure, systemic lupus erythematosus, . MYCOPHENOLATE MOFETIL dosage: unknown. During the same period patient was treated with MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL, AZATHIOPRINE, METHYLPREDNISOLONE, CYCLOPHOSPHAMIDE. Patient was hospitalized and became disabled. Patient recovered.

Sutent Side Effects Report #5611301-3
SUTENT problem was reported by a Consumer or non-health professional from UNITED STATES on Jan 28, 2008. Female patient, weighting 162.0 lb, was diagnosed with lung neoplasm malignant and was treated with SUTENT. After drug was administered, patient experienced the following problems/side effects: haematocrit decreased, perianal abscess, pyrexia, . SUTENT dosage: unknown. During the same period patient was treated with TAXOTERE. Patient was hospitalized. Patient recovered.

Sutent Side Effects Report #5611426-2
Health Professional from UNITED STATES reported SUTENT problem on Jan 11, 2008. Female patient, weighting 112.4 lb, was diagnosed with renal cell carcinoma and was treated with SUTENT. After drug was administered, patient experienced the following problems/side effects: haematocrit decreased, monocyte count increased, pancytopenia, platelet count decreased, white blood cell count decreased, . SUTENT dosage: unknown. Patient recovered.


Erlotinib Side Effects Report #5616150-8
ERLOTINIB problem was reported by a Physician from UNITED STATES on Jan 18, 2008. Female patient, 47 years of age, weighting 168.0 lb, was diagnosed with non-small cell lung cancer and was treated with ERLOTINIB. After drug was administered, patient experienced the following problems/side effects: haematocrit decreased, haemoglobin decreased, haemoptysis, . ERLOTINIB dosage: 150 MG, QD, ORAL. During the same period patient was treated with BEVACIZUMAB, LIDOCAINE, CODEINE SUL. Patient was hospitalized. Patient recovered.

Zyprexa Side Effects Report #5616506-3
Physician from UNITED STATES reported ZYPREXA problem on Jan 28, 2008. Female patient, weighting 293.9 lb, was diagnosed with schizophrenia and was treated with ZYPREXA. After drug was administered, patient experienced the following problems/side effects: haematocrit decreased, haemoglobin decreased, panic attack, type 2 diabetes mellitus, weight increased, . ZYPREXA dosage: unknown. Patient recovered.

Heparin Side Effects Report #5633076-4
HEPARIN problem was reported by a Pharmacist from UNITED STATES on Feb 21, 2008. Female patient, 48 years of age, weighting 162.5 lb, was diagnosed with deep vein thrombosis and was treated with HEPARIN. After drug was administered, patient experienced the following problems/side effects: haematocrit decreased, haemoglobin decreased, occult blood positive, platelet count decreased, . HEPARIN dosage: unknown. During the same period patient was treated with ZOLOFT, LISINOPRIL, PROTONIX, PREDNISONE, EFFEXOR, ADVAIR DISKUS. Patient was hospitalized. Patient recovered.

Pegasys Side Effects Report #5633304-5
Health Professional from UNITED STATES reported PEGASYS problem on Feb 12, 2008. Male patient, 59 years of age, weighting 172.6 lb, was diagnosed with hepatitis c and was treated with PEGASYS. After drug was administered, patient experienced the following problems/side effects: haematocrit decreased, haemoglobin decreased, leukodystrophy, optic ischaemic neuropathy, platelet count decreased, red blood cell sedimentation rate increased, white blood cell count decreased, . PEGASYS dosage: REPORTED AS 180MCG/0.5ML. Patient recovered.

Warfarin Side Effects Report #5642781-5
WARFARIN problem was reported by a Pharmacist from UNITED STATES on Feb 27, 2008. Male patient, 83 years of age, was diagnosed with atrial fibrillation and was treated with WARFARIN. After drug was administered, patient experienced the following problems/side effects: haematocrit decreased, haemoglobin decreased, platelet count increased, red blood cell count decreased, . WARFARIN dosage: 5MG EVERY DAY PO. Patient died on 11/05/2007.


Renagel Side Effects Report #5643093-6
Consumer or non-health professional from TAIWAN, PROVINCE OF CHINA reported RENAGEL problem on Feb 12, 2008. Male patient, 73 years of age, was diagnosed with hyperphosphataemia and was treated with RENAGEL. After drug was administered, patient experienced the following problems/side effects: haematocrit decreased, haemoglobin decreased, hepatic cirrhosis, hepatic neoplasm malignant recurrent, occult blood positive, platelet count decreased, red blood cell count decreased, white blood cell count decreased, . RENAGEL dosage: unknown. During the same period patient was treated with DIOVAN, BETALOC SA, CEREMIN. Patient was hospitalized. Patient recovered.

Warfarin Side Effects Report #5644224-4
WARFARIN problem was reported by a Pharmacist from UNITED STATES on Feb 27, 2008. Male patient, 55 years of age, was diagnosed with transient ischaemic attack, pain and was treated with WARFARIN. After drug was administered, patient experienced the following problems/side effects: haematocrit decreased, haemoglobin decreased, haemorrhage, international normalised ratio decreased, international normalised ratio increased, . WARFARIN dosage: 3MG EVERY DAY PO. During the same period patient was treated with OXYCODONE AND ACETAMINOPHEN. Patient was hospitalized. Patient recovered.

Enbrel Side Effects Report #5582827-6
Physician from JAPAN reported ENBREL problem on Dec 25, 2007. Female patient, weighting 114.6 lb, was diagnosed with rheumatoid arthritis, osteoporosis, gastritis, latent tuberculosis and was treated with ENBREL. After drug was administered, patient experienced the following problems/side effects: haematocrit decreased, haemoglobin decreased, intracranial aneurysm, subarachnoid haemorrhage, . ENBREL dosage: unknown. During the same period patient was treated with RISEDRONATE, ALFAROL, GASTER, PREDONINE, LOXONIN, SELBEX, ISCOTIN, ASPARA. Patient was hospitalized. Patient recovered.

Heparin Side Effects Report #5585962-1
HEPARIN problem was reported by a Consumer or non-health professional from UNITED STATES on Dec 31, 2007. Female patient, 67 years of age, weighting 119.0 lb, was diagnosed with percutaneous coronary intervention and was treated with HEPARIN. After drug was administered, patient experienced the following problems/side effects: haematocrit decreased, haematoma, haemoglobin decreased, . HEPARIN dosage: unknown. During the same period patient was treated with CLOPIDOGREL, EPTIFIBATIDE, ASPIRIN. Patient was hospitalized. Patient recovered.

Eptifibatide Side Effects Report #5587744-3
Physician from UNITED STATES reported EPTIFIBATIDE problem on Jan 02, 2008. Female patient, 67 years of age, weighting 119.1 lb, was diagnosed with percutaneous coronary intervention and was treated with EPTIFIBATIDE. After drug was administered, patient experienced the following problems/side effects: haematocrit decreased, haemoglobin decreased, wound secretion, . EPTIFIBATIDE dosage: unknown. During the same period patient was treated with CLOPIDOGREL, HEPARIN, ACETYLSALICYLIC ACID SRT. Patient was hospitalized. Patient recovered.


Angiomax Side Effects Report #5592616-4
ANGIOMAX problem was reported by a Health Professional from UNITED STATES on Apr 10, 2007. Female patient, 93 years of age, was diagnosed with percutaneous coronary intervention and was treated with ANGIOMAX. After drug was administered, patient experienced the following problems/side effects: haematocrit decreased, haematoma, haemoglobin decreased, pulmonary oedema, renal failure, . ANGIOMAX dosage: unknown. Patient died on 04/01/2007.

Sutent Side Effects Report #5595339-0
Health Professional from UNITED STATES reported SUTENT problem on Jan 09, 2008. Female patient, weighting 112.4 lb, was diagnosed with renal cell carcinoma and was treated with SUTENT. After drug was administered, patient experienced the following problems/side effects: haematocrit decreased, monocyte count increased, pancytopenia, platelet count decreased, white blood cell count decreased, . SUTENT dosage: unknown. Patient recovered.

Gemzar Side Effects Report #5597428-3
GEMZAR problem was reported by a Physician from JAPAN on Jan 11, 2008. Male patient, weighting 143.5 lb, was diagnosed with large cell lung cancer stage iv, pain and was treated with GEMZAR. After drug was administered, patient experienced the following problems/side effects: haematocrit decreased, haemoglobin decreased, lymphadenopathy, lymphocyte count decreased, malignant neoplasm progression, metastases to adrenals, metastases to peritoneum, pneumonia, red blood cell count decreased, . GEMZAR dosage: 1400 MG, OTHER. During the same period patient was treated with CISPLATIN, VOLTAREN, LENDORMIN, GASTER D, LOXONIN, NORVASC. Patient was hospitalized. Patient recovered.

Topotecan Side Effects Report #5605607-1
Health Professional from UNITED STATES reported TOPOTECAN problem on Jan 25, 2008. Female patient, weighting 135.3 lb, was diagnosed with cervix carcinoma and was treated with TOPOTECAN. After drug was administered, patient experienced the following problems/side effects: haematocrit decreased, haemoglobin decreased, vaginal haemorrhage, . TOPOTECAN dosage: unknown. Patient was hospitalized. Patient recovered.

Revlimid Side Effects Report #5633540-8
REVLIMID problem was reported by a Health Professional from UNITED STATES on Nov 14, 2007. Male patient, 57 years of age, was diagnosed with multiple myeloma and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: haematocrit decreased, . REVLIMID dosage: 25 MG, DAILY X 21 DAYS, ORAL. During the same period patient was treated with DEXAMETHASONE, TRAMADOL PM, AMBIEN CR, PROTONIX. Patient recovered.

Revlimid Side Effects Report #5637854-7
Health Professional from UNITED STATES reported REVLIMID problem on Dec 04, 2007. Female patient, 68 years of age, was diagnosed with multiple myeloma and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: haematocrit decreased, haemoglobin decreased, herpes zoster, tremor, . REVLIMID dosage: 25 MG, X 21 DAYS, ORAL. During the same period patient was treated with VELCADE, ASPIRIN. Patient recovered.

Revlimid Side Effects Report #5638365-5
REVLIMID problem was reported by a Consumer or non-health professional from UNITED STATES on Nov 19, 2007. Male patient was diagnosed with multiple myeloma and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: haematocrit decreased, red blood cell count decreased, . REVLIMID dosage: 25 MG, DAILY, ORAL. Patient recovered.

Prednisolone Side Effects Report #5547328-X
Consumer or non-health professional from JAPAN reported PREDNISOLONE problem on Nov 20, 2007. Male patient, 46 years of age, weighting 134.7 lb, was diagnosed with systemic lupus erythematosus and was treated with PREDNISOLONE. After drug was administered, patient experienced the following problems/side effects: haematocrit decreased, immunosuppression, nocardiosis, opportunistic infection, . PREDNISOLONE dosage: 40 MG/D. Patient was hospitalized. Patient recovered.

Arixtra Side Effects Report #5551086-2
ARIXTRA problem was reported by a Consumer or non-health professional from UNITED STATES on Dec 06, 2007. Female patient, 70 years of age, was diagnosed with deep vein thrombosis and was treated with ARIXTRA. After drug was administered, patient experienced the following problems/side effects: haematocrit decreased, haematoma, oedema peripheral, . ARIXTRA dosage: 7.5MG PER DAY. During the same period patient was treated with COUMADIN. Patient was hospitalized. Patient recovered.

Heparin Side Effects Report #5557825-9
Consumer or non-health professional from UNITED STATES reported HEPARIN problem on Dec 10, 2007. Female patient, 67 years of age, weighting 119.0 lb, was diagnosed with percutaneous coronary intervention and was treated with HEPARIN. After drug was administered, patient experienced the following problems/side effects: haematocrit decreased, haematoma, haemoglobin decreased, . HEPARIN dosage: unknown. During the same period patient was treated with CLOPIDOGREL, EPTIFIBATIDE. Patient was hospitalized. Patient recovered.

Warfarin Side Effects Report #5562903-4
WARFARIN problem was reported by a Pharmacist from UNITED STATES on Dec 12, 2007. Male patient, 55 years of age, was diagnosed with transient ischaemic attack, pain and was treated with WARFARIN. After drug was administered, patient experienced the following problems/side effects: haematocrit decreased, haemoglobin decreased, haemorrhage, international normalised ratio increased, . WARFARIN dosage: 3MG EVERY DAY PO. During the same period patient was treated with OXYCODONE AND ACETAMINOPHEN. Patient was hospitalized. Patient recovered.

Warfarin Side Effects Report #5562949-6
Pharmacist from UNITED STATES reported WARFARIN problem on Dec 12, 2007. Male patient, 83 years of age, was diagnosed with atrial fibrillation and was treated with WARFARIN. After drug was administered, patient experienced the following problems/side effects: haematocrit decreased, haemoglobin decreased, platelet count increased, red blood cell count decreased, . WARFARIN dosage: 5MG EVERY DAY PO. Patient died on 11/05/2007.

Tracleer Side Effects Report #5569966-0
TRACLEER problem was reported by a Health Professional from GERMANY on Dec 04, 2007. Male patient, 82 years of age, was treated with TRACLEER. After drug was administered, patient experienced the following problems/side effects: haematocrit decreased, haemoglobin decreased, . TRACLEER dosage: 62.5 MG, BID, ORAL. Patient was hospitalized. Patient recovered.

Eptifibatide Side Effects Report #5574374-2
Physician from UNITED STATES reported EPTIFIBATIDE problem on Dec 13, 2007. Female patient, 67 years of age, weighting 119.1 lb, was diagnosed with percutaneous coronary intervention and was treated with EPTIFIBATIDE. After drug was administered, patient experienced the following problems/side effects: haematocrit decreased, haemoglobin decreased, post procedural complication, wound secretion, . EPTIFIBATIDE dosage: 3.5 ML; QH; IV. During the same period patient was treated with CLOPIDOGREL, HEPARIN. Patient was hospitalized. Patient recovered.

Dacogen Side Effects Report #5575241-0
DACOGEN problem was reported by a Physician from UNITED STATES on Dec 11, 2007. Male patient, 62 years of age, weighting 202.0 lb, was diagnosed with myelodysplastic syndrome and was treated with DACOGEN. After drug was administered, patient experienced the following problems/side effects: haematocrit decreased, haematoma, haemoglobin decreased, neutrophil count decreased, open wound, platelet count decreased, white blood cell count decreased, wound infection staphylococcal, . DACOGEN dosage: 42 MG, 1 IN 1 DAY, INTRAVENOUS; 32 MG, 1 IN 1 DAY, INTRAVENOUS. During the same period patient was treated with SYNTHROID, PRILOSEC, PROCTOL, METOPROLOL TARTRATE, FENTANYL PATCH, PHOSPHORUS, OXYCODONE. Patient recovered.

Actos Side Effects Report #5578785-0
Health Professional from UNITED STATES reported ACTOS problem on Dec 18, 2007. Female patient, 71 years of age, weighting 155.0 lb, was diagnosed with type 2 diabetes mellitus, osteoarthritis and was treated with ACTOS. After drug was administered, patient experienced the following problems/side effects: haematocrit decreased, hip arthroplasty, post procedural haemorrhage, small intestinal haemorrhage, . ACTOS dosage: 15 MG, 1 IN 1 D, PER ORAL. During the same period patient was treated with CELEBREX, METFORMIN, NIACIN, ACCURETIC, NEXIUM, VERAPAMIL ER, ASPIRIN. Patient was hospitalized. Patient recovered.

Ranexa Side Effects Report #5508747-0
RANEXA problem was reported by a Physician from UNITED STATES on Jan 03, 2007. Male patient, 80 years of age, was diagnosed with angina pectoris and was treated with RANEXA. After drug was administered, patient experienced the following problems/side effects: haematocrit decreased, haemoglobin decreased, neutropenia, red blood cell count decreased, white blood cell count decreased, . RANEXA dosage: 50 MG, BID, ORAL. During the same period patient was treated with PLAVIX, ASPIRIN, NITROGLYCERIN, LIPITOR, FLOMAX. Patient recovered.

Zoloft Side Effects Report #5522381-8
Health Professional from UNITED STATES reported ZOLOFT problem on Nov 08, 2007. Female patient, 43 years of age, was diagnosed with depression and was treated with ZOLOFT. After drug was administered, patient experienced the following problems/side effects: haematocrit decreased, hepatic steatosis, pancreatic mass, pancreatitis, vomiting, . ZOLOFT dosage: unknown. During the same period patient was treated with CYMBALTA, SYNTHROID, METFORMIN HYDROCHLORIDE, DOXEPIN, ESTRATEST, BYETTA, ACIPHEX, LEVSIN. Patient was hospitalized. Patient recovered.

Warfarin Side Effects Report #5483250-5
WARFARIN problem was reported by a Consumer or non-health professional from TURKEY on Sept 24, 2007. Male patient, 62 years of age, was diagnosed with pulmonary embolism and was treated with WARFARIN. After drug was administered, patient experienced the following problems/side effects: haematocrit decreased, haematoma, international normalised ratio increased, platelet count decreased, . WARFARIN dosage: unknown. Patient was hospitalized. Patient recovered.

Arixtra Side Effects Report #5486451-5
Consumer or non-health professional from UNITED STATES reported ARIXTRA problem on Oct 11, 2007. Female patient, 70 years of age, was diagnosed with deep vein thrombosis and was treated with ARIXTRA. After drug was administered, patient experienced the following problems/side effects: haematocrit decreased, haematoma, oedema peripheral, . ARIXTRA dosage: 7.5MG PER DAY. During the same period patient was treated with COUMADIN. Patient was hospitalized. Patient recovered.

Prograf Side Effects Report #5491453-9
PROGRAF problem was reported by a Physician from UNITED STATES on Oct 05, 2007. Male patient, 17 years of age, weighting 157.6 lb, was diagnosed with renal transplant and was treated with PROGRAF. After drug was administered, patient experienced the following problems/side effects: haematocrit decreased, haemoglobin decreased, pneumonia aspiration, . PROGRAF dosage: unknown. During the same period patient was treated with DACLIZUMAB, NORVASC, SEPTRA, SINGULAIR, PROTONIX, TIMENTIN. Patient was hospitalized. Patient recovered.

Avandia Side Effects Report #5499376-6
Consumer or non-health professional from UNITED STATES reported AVANDIA problem on Oct 24, 2007. Male patient, 52 years of age, was treated with AVANDIA. After drug was administered, patient experienced the following problems/side effects: haematocrit decreased, haematuria, haemoglobin decreased, platelet count increased, . AVANDIA dosage: unknown. During the same period patient was treated with METFORMIN, DIOVAN, VYTORIN, GABAPENTIN. Patient was hospitalized. Patient recovered.

Mirena Side Effects Report #5503306-8
MIRENA problem was reported by a Health Professional from UNITED STATES on Oct 24, 2007. Female patient, 20 years of age, weighting 231.5 lb, was treated with MIRENA. After drug was administered, patient experienced the following problems/side effects: haematocrit decreased, haemoglobin decreased, intra-uterine contraceptive device expelled, vaginal haemorrhage, . MIRENA dosage: unknown. Patient recovered.

Velcade Side Effects Report #5458068-X
Physician from UNITED KINGDOM reported VELCADE problem on June 11, 2007. Female patient, 71 years of age, weighting 140.2 lb, was diagnosed with waldenstrom's macroglobulinaemia and was treated with VELCADE. After drug was administered, patient experienced the following problems/side effects: haematocrit decreased, lymphocyte count decreased, neutropenia, platelet count decreased, red blood cell count decreased, white blood cell count decreased, . VELCADE dosage: 2.20 MG, IV BOLUS. During the same period patient was treated with RITUXIMAB, ACYCLOVIR, AMITRIPTYLINE, LEVOTHYROXINE, LANSOPRAZOLE. Patient recovered.

Prednisone Side Effects Report #5470166-3
PREDNISONE problem was reported by a Physician from UNITED STATES on Sept 11, 2007. Female patient, 22 years of age, was treated with PREDNISONE. After drug was administered, patient experienced the following problems/side effects: haematocrit decreased, immune system disorder, immunosuppression, infection, nephrogenic systemic fibrosis, oedema peripheral, peau d'orange, rash maculo-papular, . PREDNISONE dosage: 15 MG, QD,. During the same period patient was treated with MYCOPHENOLATE MOFETIL, TACROLIMUS, SULFAMETHOXAZOLE AND TRIMETHOPRIM, MAGNESIUM OXIDE, GANCICLOVIR, CLONIDINE, ASPIRIN, OMEPRAZOLE. Patient recovered.

Malarone Side Effects Report #5403989-7
Pharmacist from UNITED KINGDOM reported MALARONE problem on July 25, 2007. Male patient was diagnosed with malaria prophylaxis and was treated with MALARONE. After drug was administered, patient experienced the following problems/side effects: haematocrit decreased, red blood cell count decreased, thrombocytopenia, . MALARONE dosage: unknown. Patient recovered.

Clozaril Side Effects Report #5406757-5
CLOZARIL problem was reported by a Health Professional from UNITED STATES on July 29, 2007. Female patient, 56 years of age, weighting 130.0 lb, was diagnosed with schizophrenia and was treated with CLOZARIL. After drug was administered, patient experienced the following problems/side effects: haematocrit decreased, haemoglobin decreased, lymphocyte count decreased, monocyte count decreased, neutrophil count decreased, platelet count decreased, red blood cell count decreased, red cell distribution width increased, . CLOZARIL dosage: 700 MG, QHS. During the same period patient was treated with RADIATION, CARBOPLATIN, ETOPOSIDE. Patient recovered.

Enoxaparin Side Effects Report #5409654-4
Pharmacist from UNITED STATES reported ENOXAPARIN problem on Aug 08, 2007. Male patient, 60 years of age, was diagnosed with atrial fibrillation and was treated with ENOXAPARIN. After drug was administered, patient experienced the following problems/side effects: haematocrit decreased, haematoma, haemoglobin decreased, haemorrhage, . ENOXAPARIN dosage: unknown. Patient was hospitalized. Patient recovered.

Paclitaxel Side Effects Report #5414965-2
PACLITAXEL problem was reported by a Pharmacist from UNITED STATES on Aug 13, 2007. Female patient, 79 years of age, weighting 150.0 lb, was diagnosed with fallopian tube cancer, ovarian cancer and was treated with PACLITAXEL. After drug was administered, patient experienced the following problems/side effects: haematocrit decreased, haemoglobin decreased, nausea, red blood cell count decreased, syncope, vomiting, white blood cell count decreased, . PACLITAXEL dosage: unknown. Patient was hospitalized. Patient recovered.

Cetuximab Side Effects Report #5416830-3
Health Professional from UNITED STATES reported CETUXIMAB problem on Aug 15, 2007. Female patient, weighting 204.0 lb, was diagnosed with lung neoplasm malignant and was treated with CETUXIMAB. After drug was administered, patient experienced the following problems/side effects: haematocrit decreased, haemoglobin decreased, upper gastrointestinal haemorrhage, . CETUXIMAB dosage: 500MG WEEKLY IV. Patient was hospitalized. Patient recovered.

Clozaril Side Effects Report #5420469-3
CLOZARIL problem was reported by a Health Professional from UNITED STATES on Aug 15, 2007. Female patient, 56 years of age, weighting 130.0 lb, was diagnosed with schizophrenia and was treated with CLOZARIL. After drug was administered, patient experienced the following problems/side effects: haematocrit decreased, haemoglobin decreased, lymphocyte count decreased, monocyte count decreased, neutrophil count decreased, platelet count decreased, red blood cell count decreased, red cell distribution width increased, . CLOZARIL dosage: 700 MG, QHS. During the same period patient was treated with RADIATION, CARBOPLATIN, ETOPOSIDE. Patient recovered.

Letrozole Side Effects Report #5386231-5
Physician from GERMANY reported LETROZOLE problem on July 03, 2007. Female patient was diagnosed with breast cancer and was treated with LETROZOLE. After drug was administered, patient experienced the following problems/side effects: haematocrit decreased, haematological malignancy, haemoglobin decreased, platelet count decreased, . LETROZOLE dosage: 2.5 MG, QD. Patient recovered.